Key Market Indicators
Belgian analgesic medicine sales are expected to reach $296.28 million by 2026. This is a 0.3% annual growth rate from 2021's sales of $299.42 million. Since 2007, the market has grown an average of 1.9% each year. In 2021, Belgium ranked 7th globally in analgesic sales. Australia overtook the country with $299.42 million. Spain, Canada and Italy ranked 2nd, 3rd and 4th respectively.
